Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen
Access Bio receives W2b research support from Gates Foundation
By 윤정현Published : Sept. 8, 2016 - 14:23
[DISCLOSURE] Access Bio (950130) -- which specializes in research, development and manufacturing of in vitro rapid diagnostic tests, biosensor and molecular diagnostic products -- has received 2 billion won (US$ 1.82 million) from the Bill & Melinda Gates Foundation.
The foundation will provide funds until Feb. 1, 2018, to support its research and development to improve sensitivity of malaria diagnostic methods, the company added.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
The foundation will provide funds until Feb. 1, 2018, to support its research and development to improve sensitivity of malaria diagnostic methods, the company added.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
